List of DCPrime patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11027001 Therapeutic cancer vaccines derived from a novel dendritic cell line	Patent 11027001 was granted and assigned to DCPrime on June, 2021 by the United States Patent and Trademark Office.	DCPrime	DCPrime	United States Patent and Trademark Office	11027001	June 8, 2021
‌ US Patent 10064923 Therapeutic cancer vaccines derived from a novel dendritic cell line	Patent 10064923 was granted and assigned to DCPrime on September, 2018 by the United States Patent and Trademark Office.	DCPrime	DCPrime	United States Patent and Trademark Office	10064923	September 4, 2018
‌ US Patent 11071778 Combination product for use in tumor vaccination	Patent 11071778 was granted and assigned to DCPrime on July, 2021 by the United States Patent and Trademark Office.	DCPrime	DCPrime	United States Patent and Trademark Office	11071778	July 27, 2021
‌ US Patent 8470789 Method for inducing and accelerating cells	Patent 8470789 was granted and assigned to DCPrime on June, 2013 by the United States Patent and Trademark Office.		DCPrime	United States Patent and Trademark Office	8470789	June 25, 2013
‌ US Patent 11052144 Methods of tumor vaccination	Patent 11052144 was granted and assigned to DCPrime on July, 2021 by the United States Patent and Trademark Office.	DCPrime	DCPrime	United States Patent and Trademark Office	11052144	July 6, 2021